DarioHealth (DRIO) Net Cash Flow (2012 - 2026)

DarioHealth (DRIO) has reported Net Cash Flow for 15 consecutive years, with -$8.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Net Cash Flow fell 40.65% year-over-year to -$8.4 million; the trailing twelve-month figure through Jun 2026 stood at -$15.4 million (down 826.43% YoY), and the FY2025 full-year result was -$6.0 million, up 33.41% from the prior year.
• Net Cash Flow eased to -$8.4 million in Q2 2026 per DRIO's latest filing, from -$6.9 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $19.7 million in Q1 2022 and bottomed at -$11.4 million in Q2 2024.
• Historically, Net Cash Flow has averaged -$1.6 million across 5 years, with a median of -$7.1 million in 2024.
• The sharpest annual moves came in 2024 and 2026: Net Cash Flow jumped 255.87% in 2024, then sank 6272.07% in 2026.
• Over 5 years, Net Cash Flow stood at -$7.7 million in 2022, then grew by 4.02% to -$7.4 million in 2023, then surged by 255.87% to $11.6 million in 2024, then plunged by 187.56% to -$10.1 million in 2025, then increased by 17.39% to -$8.4 million in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered -$8.4 million, -$6.9 million, and -$10.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.